17.08.2013 Views

Singapore Banking Sector - Phillip Securities Pte Ltd

Singapore Banking Sector - Phillip Securities Pte Ltd

Singapore Banking Sector - Phillip Securities Pte Ltd

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />

Results Season Takeaways<br />

Report type: Update<br />

<strong>Sector</strong> Overview<br />

The <strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong> provides traditional lending<br />

and depository functions, as well as other services in the<br />

areas of commercial banking, financial advisory, asst<br />

management, insurance broking and capital market<br />

services.<br />

Post Results Highlight<br />

Non Interest income<br />

Non Interest Income beat expectations due to strong<br />

performance of net trading income<br />

Net trading income likely due to strong performances in<br />

indices in 1Q12 leading higher valuation gains<br />

Strong performances unlikely to be repeated in 2Q12 or<br />

FY12, given currently macroeconomic uncertainties.<br />

Net Interest Margins<br />

NIMs improved 1-4bps in 1Q12, with OCBC’s NIMs<br />

growth weakest at 1bps and DBS strongest at 4bps<br />

DBS and OCBC guides possible upside potentials while<br />

UOB guides that NIMs may have peaked<br />

We expect NIMs to remain around current range<br />

Loans growth outlook<br />

Loans growth have slowed as guided by Managements<br />

General Commerce loans slow due to decrease in RMB<br />

appreciation driven trades, but expected to remain<br />

relatively strong for the rest of FY2012<br />

Strong growth of USD deposits to benefit growth of trade<br />

finance business for UOB and DBS<br />

We expect loans to SMEs to drive loans growth for<br />

FY2012, and contributing to growth of non-interest<br />

income<br />

Investment actions<br />

Based on 5 year historical price to book, all three banks are<br />

below historical mean PB ratio, possibly indicating cheap<br />

pricing based on valuations. While uncertainties in the<br />

current macroeconomic conditions continue to suppress<br />

prices, we think that DBS will outperform its local peers with<br />

continued growth and strong performance. We rate DBS as<br />

“Accumulate” while maintaining our “Neutral” call on UOB<br />

and OCBC.<br />

MICA (P) 012/01/2012<br />

Ref. No.: SG2012_0136 1 of 10<br />

<strong>Phillip</strong> <strong>Securities</strong> Research <strong>Pte</strong> <strong>Ltd</strong><br />

18 May 2012<br />

<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />

Company Rating Price TP Upside M.Cap.<br />

(S$) (S$) (%) (US$'mn)<br />

DBS Group Holdings <strong>Ltd</strong> Accumulate 13.30 14.90 12.0% 25,220<br />

Overseas Chinese<br />

<strong>Banking</strong> Corp Neutral 8.43 8.20 -2.7% 22,639<br />

United Overseas Bank Neutral 17.48 17.50 0.1% 21,582<br />

Source: Bloomberg, PSR<br />

Analyst<br />

Ken Ang<br />

Kenangw y@phillip.com.sg<br />

Tel : (65) 6531 1793


<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />

<strong>Singapore</strong> Equities Research<br />

18 May 2012<br />

Earnings surprise largely attributed to likely nonrecurring<br />

strong performance of net trading income<br />

Fig 1: Strong performance of Indices supported net<br />

trading income in 1Q12, but largely flat since then<br />

FTSE Straits Times Index – trending downwards since<br />

1Q12, expected to be relatively flat for rest of FY2012<br />

FTSE Bursa Malaysia KLCI – Growth may be further<br />

stimulated with possible policy rate cuts<br />

Indonesia Sharia Stock Index – higher highs since 1Q12,<br />

expected to perform relatively stronger than the STI<br />

Thailand SET Index– higher highs since 1Q12, expected to<br />

perform relatively stronger than the STI<br />

Source: bigcharts.marketwatch.com, <strong>Phillip</strong> <strong>Securities</strong> Research<br />

2 of 10<br />

Higher trading income contributed largely to the positive<br />

earnings surprise. Trading income generally refers to<br />

income from customer flow of treasury products, and from<br />

trading activities including realized gains from sale of AFS<br />

securities, and unrealized valuation gains on other products<br />

such as FVTPL. The strong performances of the indices in<br />

the Asean region may have supported the stronger net<br />

trading income through higher equity valuation gains, and<br />

greater opportunities to realize gains on AFS.<br />

Moving forward, our strategist believes that while the market<br />

outlook for export dependant countries such as <strong>Singapore</strong><br />

and Taiwan would be rather flat, countries such as Malaysia,<br />

Indonesia and Thailand are expected to experience<br />

relatively better economic growth. For Malaysia, given the<br />

lower and more stable inflation rate, growth may be further<br />

stimulated with policy rate cuts. This may benefit bonds due<br />

to their inverse correlations with interest rates, while equity<br />

securities perform in tandem with the Malaysian market.<br />

However, as observed from the graphs in Fig 1, it is unlikely<br />

for 1Q12’s strong net trading income to be repeated in 2Q12<br />

and likely for the rest of FY2012, other than realizing current<br />

valuation gains on AFS. Downward potentials to net trading<br />

income may arise from further slowdown in the global<br />

economy or from adverse developments on the debt crisis in<br />

Europe. We are unable to do a comparison between the<br />

three banks due to lack of disclosure by the banks.<br />

NIMs improved in 1Q12 from better loans pricing – likely<br />

to be stable and remain within current range for FY2012<br />

Fig 2: NIMS have been trending downwards but<br />

seems to have bottomed in 3Q11<br />

2.25<br />

2.15<br />

2.05<br />

1.95<br />

1.85<br />

1.75<br />

1.65<br />

OCBC DBS<br />

UOB<br />

2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />

Source: Company data, <strong>Phillip</strong> <strong>Securities</strong> Research<br />

NIMs have expanded across the three banks in 1Q12, with<br />

DBS the strongest at 4bps, and OCBC weakest at 1bp.<br />

UOB continued its strong rebound, increasing 3bps to<br />

register a commendable 9bps increase since hitting lows in<br />

3Q11. As previously highlighted in our 4Q11 results season<br />

takeaway report, UOB’s increase in NIMS is likely due to the<br />

offering of higher maturity loans, therefore commanding a<br />

liquidity premium. However, longer maturity loans also pose<br />

higher interest rate risks (for fixed rate loans) and credit risks.<br />

DBS and OCBC has commented that there may be potential<br />

for further NIMs expansion, while UOB guided that NIMs<br />

may have peaked. With UOB’s main overseas markets<br />

being in countries with relatively better market outlooks such<br />

as Malaysia, Indonesia and Thailand, we prefer UOB for its<br />

current high NIMs ability to increase NIMs significantly.


<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />

<strong>Singapore</strong> Equities Research<br />

18 May 2012<br />

Loans growth expected to gather momentum from<br />

slower 1Q12<br />

Fig 3: Q-Q Loans growth momentum slows in 1Q12<br />

12%<br />

10%<br />

8%<br />

6%<br />

4%<br />

2%<br />

0%<br />

-2%<br />

OCBC DBS<br />

UOB Total<br />

2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />

Fig 4: Q-Q Total loans growth among local banks<br />

negative in a few industries, but remain relatively<br />

strong in housing, FIs, Professional & private loans<br />

Total loans q-q grow th 2Q11 3Q11 4Q11 1Q12<br />

Agriculture<br />

-4.0% 9.1% 18.2% 1.3%<br />

Manufacturing<br />

12.0% 5.0% 7.2% 2.4%<br />

Building and construction 3.8% 8.4% 8.0% 1.8%<br />

General commerce<br />

24.0% 20.9% 1.9% -1.2%<br />

Transport<br />

6.1% 4.7% 4.4% -2.5%<br />

Financial institutions<br />

3.2% 9.3% 1.0% 4.9%<br />

Professional and private (business) 7.0% 3.0% 7.5% 2.1%<br />

Others<br />

10.6% 5.3% 0.3% -4.8%<br />

Housing<br />

3.0% 4.8% 3.6% 3.1%<br />

Total loans<br />

7.6% 8.0% 4.2% 1.3%<br />

Source: Company data, <strong>Phillip</strong> <strong>Securities</strong> Research<br />

Loans growth momentum has slowed, but remains positive<br />

for all three banks on an average loan balance basis. With<br />

similar guidance of low teens loans growth, we expect<br />

growth to increase for the next few quarters. We note that<br />

current gross balances were likely reduced due to the<br />

appreciation of the <strong>Singapore</strong> Dollar in 1Q12 against the<br />

Asian currencies.<br />

Fig 5: General Commerce loans VS Total Loans<br />

Growth – growth may continue in FY2012<br />

40%<br />

30%<br />

20%<br />

10%<br />

0%<br />

-10%<br />

-20%<br />

OCBC DBS<br />

UOB Total<br />

2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />

Source: Company data, <strong>Phillip</strong> <strong>Securities</strong> Research<br />

General Commerce (GC) loans have slowed, registering its<br />

first negative q-q growth since 3Q09, based on the total GC<br />

loans across the three banks. OCBC’s CEO Samuel Tsien<br />

has guided that the drop was due to a decrease in demand<br />

from the RMB appreciation driven trade financing by<br />

customers from China, as written in our OCBC 1Q12 results<br />

report dd 11 May 2012.<br />

3 of 10<br />

We expect GC loans to continue its growth in FY2012 as 1)<br />

New opportunities have risen from the deleveraging of<br />

global banks as highlighted in our <strong>Sector</strong> reports. 2)<br />

Success of <strong>Singapore</strong>’s Global Trader Program in increasing<br />

trading activities with <strong>Singapore</strong> as companies’ regional<br />

base. 3) An increase in intra Asia trade volumes.<br />

Due to the attractive returns, short term commitments and<br />

safe quality of assets as these loans are typically fully<br />

collateralized, we expect General Commerce to continue<br />

healthy loans growth in FY12. The three banks have also<br />

built up a larger funding base of USD deposits and<br />

wholesale funding, giving them the liquidity required to<br />

increase USD denominated lending.<br />

Fig 6: USD LDR continues to decrease as banks<br />

boost USD liquidity through higher deposits (UOB<br />

figs. not available)<br />

50,000<br />

40,000<br />

30,000<br />

20,000<br />

10,000<br />

0<br />

OCBC US$ DBS US$<br />

OCBC LDR DBS LDR<br />

2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />

Source: Company data, <strong>Phillip</strong> <strong>Securities</strong> Research<br />

180%<br />

170%<br />

160%<br />

150%<br />

140%<br />

130%<br />

120%<br />

110%<br />

100%<br />

DBS continues to enjoy an advantage in General commerce<br />

loans due to a larger and more established presence, while<br />

UOB may perform better than OCBC due to better liquidity<br />

management based on the LDR ratios.<br />

Rise of the SMEs – <strong>Singapore</strong> and Abroad<br />

Based on SPRING <strong>Singapore</strong>, 99% of all enterprises in<br />

<strong>Singapore</strong> are SMEs, contributing over 50% of <strong>Singapore</strong>’s<br />

GDP. Growth is likely further spurred by the low interest rate<br />

environment, and increase in intra Asian trades as the<br />

neighboring Asian countries continue to grow, although at a<br />

slower pace. The local banks have stepped in, increasing<br />

efforts to provide loans and transaction banking services,<br />

including trade financing and cash management services.<br />

While competition remains stiff for MNCs and larger SMEs,<br />

the relatively smaller sized SMEs are relatively underserved<br />

and provide opportunities for banks. Transaction <strong>Banking</strong> is<br />

especially lucrative given the potential fees and<br />

commissions and lower capital requirements.<br />

Key risks for the <strong>Sector</strong><br />

A worsening global economy may result in rise of NPLs and<br />

credit costs, as affected customers, especially SMEs and<br />

unsecured consumer loans, default on loan repayments.<br />

This may result in reduced net profits.<br />

The return of US banks flushed with USD liquidity, as<br />

suggested by OCBC’s CEO, re-entering the Asian markets<br />

may provide competition to the <strong>Singapore</strong> banks and<br />

increase NIMS pressure in the region.<br />

90%


<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />

<strong>Singapore</strong> Equities Research<br />

18 May 2012<br />

Com pany Rating FYE Price TP Upside Market Ent. Market Ent.<br />

Equity Multiple (X) Dividend Yield (%)<br />

Market price as of:<br />

Cap. Value Cap. Value Net Incom e Book Value<br />

18-May-12 (%) (S$'m n) (S$'m n) (US$'mn)(US$'mn) FY10 FY11 FY12E FY10 FY11 FY12E FY10 FY11 FY12E<br />

DBS Group Holdings <strong>Ltd</strong> Accumulate Dec 13.30 14.90 12.0% 32,140 38,494 25,220 30,277 19.7 10.6 9.3 1.2 1.1 1.0 4.2% 4.2% 4.3%<br />

Overseas Chinese <strong>Banking</strong> Corp Neutral Dec 8.43 8.20 -2.7% 28,850 19,710 22,639 15,366 12.8 12.5 11.0 1.5 1.4 1.3 3.6% 3.6% 3.6%<br />

United Overseas Bank<br />

Source: Bloomberg, PSR est.<br />

Neutral Dec 17.48 17.50 0.1% 27,503 26,169 21,582 20,521 10.2 11.8 10.5 1.4 1.3 1.2 4.0% 3.4% 3.4%<br />

4 of 10


<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />

<strong>Singapore</strong> Equities Research<br />

18 May 2012<br />

Oversea-Chinese <strong>Banking</strong> Corp – Insurance “wildcard”<br />

2,500<br />

2,000<br />

1,500<br />

1,000<br />

500<br />

0<br />

2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />

DBS Group Holdings – Most stable Non II earnings<br />

2,500<br />

2,000<br />

1,500<br />

1,000<br />

500<br />

0<br />

2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />

United Overseas Bank <strong>Ltd</strong><br />

2,500<br />

2,000<br />

1,500<br />

1,000<br />

500<br />

2.8<br />

2.6<br />

2.4<br />

2.2<br />

2.0<br />

1.8<br />

1.6<br />

1.4<br />

1.2<br />

1.0<br />

0.8<br />

2.0<br />

1.8<br />

1.6<br />

1.4<br />

1.2<br />

1.0<br />

0.8<br />

0.6<br />

0.4<br />

0<br />

2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />

OCBC - PB ratio<br />

SD+1<br />

SD-1<br />

May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />

DBS - PB ratio<br />

SD+1<br />

SD-1<br />

May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />

Source: Company data, Bloomberg, <strong>Phillip</strong> <strong>Securities</strong> Research<br />

1.83<br />

1.51<br />

1.23 1.20<br />

1.49<br />

1.23<br />

1.08<br />

0.98<br />

5 of 10<br />

- Net profit y-y growth slower than Total revenue growth<br />

8,000<br />

7,000<br />

6,000<br />

5,000<br />

4,000<br />

3,000<br />

2,000<br />

1,000<br />

0<br />

FY2009 FY2010 FY2011 FY2012<br />

Non Int Inc<br />

Fees and<br />

Comm<br />

NII<br />

Net Profit<br />

PPOP<br />

- Increasing y-y earnings from Non II, High net profit growth<br />

8,000<br />

7,000<br />

6,000<br />

5,000<br />

4,000<br />

3,000<br />

2,000<br />

1,000<br />

0<br />

FY2009 FY2010 FY2011 FY2012<br />

- Minimal y-y growth in total revenue<br />

8,000<br />

7,000<br />

6,000<br />

5,000<br />

4,000<br />

3,000<br />

2,000<br />

1,000<br />

2.4<br />

2.2<br />

2.0<br />

1.8<br />

1.6<br />

1.4<br />

1.2<br />

1.0<br />

0.8<br />

19.0<br />

17.0<br />

15.0<br />

13.0<br />

11.0<br />

9.0<br />

7.0<br />

0<br />

FY2009 FY2010 FY2011 FY2012<br />

UOB - PB ratio<br />

SD+1<br />

SD-1<br />

OCBC - PE ratio<br />

SD+1<br />

SD-1<br />

Non Int Inc<br />

Fees and<br />

Comm<br />

NII<br />

Net Profit<br />

PPOP<br />

Non Int Inc<br />

Fees and<br />

Comm<br />

NII<br />

Net Profit<br />

PPOP<br />

May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />

May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />

Source: Company data, Bloomberg, <strong>Phillip</strong> <strong>Securities</strong> Research<br />

1.83<br />

1.57<br />

1.27 1.31<br />

15.33<br />

13.64<br />

11.94


<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />

<strong>Singapore</strong> Equities Research<br />

18 May 2012<br />

25.0<br />

20.0<br />

15.0<br />

10.0<br />

5.0<br />

DBS - PE ratio<br />

SD+1<br />

SD-1<br />

-<br />

May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />

6<br />

4<br />

2<br />

0<br />

-4<br />

-6<br />

-8<br />

25 April 12 rebased<br />

-2<br />

4/25/2012 5/1/2012 5/7/2012 5/13/2012<br />

8<br />

6<br />

4<br />

2<br />

0<br />

-4<br />

-6<br />

-8<br />

OCB C<br />

DBS<br />

UOB<br />

STI<br />

1 month rebased<br />

4/17/2012 -2<br />

4/25/2012 5/3/2012 5/11/2012<br />

12<br />

10<br />

8<br />

6<br />

4<br />

2<br />

0<br />

-2<br />

-4<br />

-6<br />

-8<br />

-10<br />

OCBC<br />

DBS<br />

UOB<br />

STI<br />

OCBC<br />

DB S<br />

UOB<br />

STI<br />

3 months rebased<br />

2/17/2012 3/8/2012 3/28/2012 4/17/2012 5/7/2012<br />

Source: Company data, Bloomberg, <strong>Phillip</strong> <strong>Securities</strong> Research<br />

15.37<br />

12.47<br />

9.56<br />

6 of 10<br />

20.0<br />

18.0<br />

16.0<br />

14.0<br />

12.0<br />

10.0<br />

8.0<br />

6.0<br />

25<br />

20<br />

15<br />

10<br />

5<br />

0<br />

-10<br />

-15<br />

10<br />

5<br />

0<br />

-10<br />

-15<br />

-20<br />

-25<br />

-30<br />

25<br />

20<br />

15<br />

10<br />

5<br />

0<br />

-5<br />

-10<br />

-15<br />

-20<br />

-25<br />

-30<br />

UOB - PE ratio<br />

SD+1<br />

SD-1<br />

May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />

OCBC<br />

DBS<br />

UOB<br />

STI<br />

2 Year rebased<br />

5/19/2010 10/19/2010 3/19/2011 8/19/2011 1/19/2012<br />

OCB C<br />

DBS<br />

UOB<br />

STI<br />

1 Year rebased<br />

5/19/2011 -5 7/19/2011 9/19/201111/19/20111/19/2012 3/19/2012<br />

OCB C<br />

DBS<br />

UOB<br />

STI<br />

6 months rebased<br />

15.17<br />

13.02<br />

10.87<br />

11/18/201 -5 12/18/20111/18/2012 2/18/20123/18/2012 4/18/2012 5/18/2012<br />

Source: Company data, Bloomberg, <strong>Phillip</strong> <strong>Securities</strong> Research


<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />

<strong>Singapore</strong> Equities Research<br />

18 May 2012<br />

Important Information<br />

This publication is prepared by <strong>Phillip</strong> <strong>Securities</strong> Research <strong>Pte</strong> <strong>Ltd</strong>., 250 North Bridge Road, #06-00, Raffles City<br />

Tower, <strong>Singapore</strong> 179101 (Registration Number: 198803136N), which is regulated by the Monetary Authority of<br />

<strong>Singapore</strong> (“<strong>Phillip</strong> <strong>Securities</strong> Research”). By receiving or reading this publication, you agree to be bound by the terms<br />

and limitations set out below.<br />

This publication has been provided to you for personal use only and shall not be reproduced, distributed or published<br />

by you in whole or in part, for any purpose. If you have received this document by mistake, please delete or destroy it,<br />

and notify the sender immediately. <strong>Phillip</strong> <strong>Securities</strong> Research shall not be liable for any direct or consequential loss<br />

arising from any use of material contained in this publication.<br />

The information contained in this publication has been obtained from public sources, which <strong>Phillip</strong> <strong>Securities</strong> Research<br />

has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions<br />

(collectively, the “Research”) contained in this publication are based on such information and are expressions of belief<br />

of the individual author or the indicated source (as applicable) only. <strong>Phillip</strong> <strong>Securities</strong> Research has not verified this<br />

information and no representation or warranty, express or implied, is made that such information or Research is<br />

accurate, complete, appropriate or verified or should be relied upon as such. Any such information or Research<br />

contained in this publication is subject to change, and <strong>Phillip</strong> <strong>Securities</strong> Research shall not have any responsibility to<br />

maintain or update the information or Research made available or to supply any corrections, updates or releases in<br />

connection therewith. In no event will <strong>Phillip</strong> <strong>Securities</strong> Research or persons associated with or connected to <strong>Phillip</strong><br />

<strong>Securities</strong> Research, including but not limited its officers, directors, employees or persons involved in the preparation<br />

or issuance of this report, (i) be liable in any manner whatsoever for any consequences (including but not limited to<br />

any special, direct, indirect, incidental or consequential losses, loss of profits and damages) of any reliance or usage<br />

of this publication or (ii) accept any legal responsibility from any person who receives this publication, even if it has<br />

been advised of the possibility of such damages. You must make the final investment decision and accept all<br />

responsibility for your investment decision, including, but not limited to your reliance on the information, data and/or<br />

other materials presented in this publication.<br />

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this material are as of the date<br />

indicated and are subject to change at any time without prior notice.<br />

Past performance of any product referred to in this publication is not indicative of future results.<br />

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This<br />

publication should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own<br />

independent verification and exercise of judgment. The fact that this publication has been made available constitutes<br />

neither a recommendation to enter into a particular transaction, nor a representation that any product described in this<br />

material is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may<br />

be described in this publication involve significant risks and may not be suitable for all investors, and that any decision<br />

to enter into transactions involving such products should not be made, unless all such risks are understood and an<br />

independent determination has been made that such transactions would be appropriate. Any discussion of the risks<br />

contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete<br />

discussion of such risks.<br />

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any<br />

decision to purchase any product mentioned in this research should take into account existing public information,<br />

including any registered prospectus in respect of such product.<br />

<strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or connected to <strong>Phillip</strong> <strong>Securities</strong> Research, including but not<br />

limited to its officers, directors, employees or persons involved in the preparation or issuance of this report, may<br />

provide an array of financial services to a large number of corporations in <strong>Singapore</strong> and worldwide, including but not<br />

limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting<br />

activities), brokerage or securities trading activities. <strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or<br />

connected to <strong>Phillip</strong> <strong>Securities</strong> Research, including but not limited to its officers, directors, employees or persons<br />

involved in the preparation or issuance of this report, may have participated in or invested in transactions with the<br />

issuer(s) of the securities mentioned in this publication, and may have performed services for or solicited business<br />

from such issuers. Additionally, <strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or connected to <strong>Phillip</strong><br />

<strong>Securities</strong> Research, including but not limited to its officers, directors, employees or persons involved in the<br />

7 of 10


<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />

<strong>Singapore</strong> Equities Research<br />

18 May 2012<br />

preparation or issuance of this report, may have provided advice or investment services to such companies and<br />

investments or related investments, as may be mentioned in this publication.<br />

<strong>Phillip</strong> <strong>Securities</strong> Research or persons associated with or connected to <strong>Phillip</strong> <strong>Securities</strong> Research, including but not<br />

limited to its officers, directors, employees or persons involved in the preparation or issuance of this report may, from<br />

time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase<br />

or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other<br />

compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars<br />

and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign<br />

currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price<br />

or income return of the investment.<br />

To the extent permitted by law, <strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or connected to <strong>Phillip</strong><br />

<strong>Securities</strong> Research, including but not limited to its officers, directors, employees or persons involved in the<br />

preparation or issuance of this report, may at any time engage in any of the above activities as set out above or<br />

otherwise hold a interest, whether material or not, in respect of companies and investments or related investments,<br />

which may be mentioned in this publication. Accordingly, information may be available to <strong>Phillip</strong> <strong>Securities</strong> Research,<br />

or persons associated with or connected to <strong>Phillip</strong> <strong>Securities</strong> Research, including but not limited to its officers,<br />

directors, employees or persons involved in the preparation or issuance of this report, which is not reflected in this<br />

material, and <strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or connected to <strong>Phillip</strong> <strong>Securities</strong> Research,<br />

including but not limited to its officers, directors, employees or persons involved in the preparation or issuance of this<br />

report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following<br />

its publication. <strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or connected to <strong>Phillip</strong> <strong>Securities</strong> Research,<br />

including but not limited its officers, directors, employees or persons involved in the preparation or issuance of this<br />

report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of<br />

this material.<br />

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person<br />

or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the<br />

applicable law or regulation or which would subject <strong>Phillip</strong> <strong>Securities</strong> Research to any registration or licensing or other<br />

requirement, or penalty for contravention of such requirements within such jurisdiction.<br />

Section 27 of the Financial Advisers Act (Cap. 110) of <strong>Singapore</strong> and the MAS Notice on Recommendations on<br />

Investment Products (FAA-N01) do not apply in respect of this publication.<br />

This material is intended for general circulation only and does not take into account the specific investment objectives,<br />

financial situation or particular needs of any particular person. The products mentioned in this material may not be<br />

suitable for all investors and a person receiving or reading this material should seek advice from a professional and<br />

financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such<br />

products, taking into account the specific investment objectives, financial situation or particular needs of that person,<br />

before making a commitment to invest in any of such products.<br />

Please contact <strong>Phillip</strong> <strong>Securities</strong> Research at [65 65311240] in respect of any matters arising from, or in connection<br />

with, this document.<br />

This report is only for the purpose of distribution in <strong>Singapore</strong>.<br />

8 of 10


<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />

<strong>Singapore</strong> Equities Research<br />

18 May 2012<br />

Contact Information (<strong>Singapore</strong> Research Team)<br />

Chan Wai Chee Lee Kok Joo, CFA Joshua Tan<br />

CEO, Research Head of Research Strategist<br />

Special Opportunities S-Chips, Strategy +65 6531 1249<br />

+65 6531 1231 +65 6531 1685 joshuatan@phillip.com.sg<br />

yebo@phillip.com.sg leekj@phillip.com.sg<br />

Magdalene Choong Go Choon Koay, Bryan Derrick Heng<br />

Investment Analyst Investment Analyst Investment Analyst<br />

SG & US Financials, Gaming Property Transportation, Telecom.<br />

+65 6531 1791 +65 6531 1792 +65 6531 1221<br />

magdalenechoongss@phillip.com.sg gock@phillip.com.sg derrickhengch@phillip.com.sg<br />

Travis Seah Ken Ang Peter Lee<br />

Investment Analyst Investment Analyst Research Assistant<br />

REITS Financials General Enquiries<br />

+65 6531 1229 +65 6531 1793 +65 6531 1240 (Phone)<br />

travisseahhk@phillip.com.sg kenangwy@phillip.com.sg +65 6336 7607 (Fax)<br />

research@phillip.com.sg<br />

9 of 10


<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />

<strong>Singapore</strong> Equities Research<br />

18 May 2012<br />

Contact Information (Regional Member Companies)<br />

SINGAPORE<br />

<strong>Phillip</strong> <strong>Securities</strong> <strong>Pte</strong> <strong>Ltd</strong><br />

Raffles City Tower<br />

250, North Bridge Road #06-00<br />

<strong>Singapore</strong> 179101<br />

Tel : (65) 6533 6001<br />

Fax : (65) 6535 6631<br />

Website: www.poems.com.sg<br />

HONG KONG<br />

<strong>Phillip</strong> <strong>Securities</strong> (HK) <strong>Ltd</strong><br />

Exchange Participant of the Stock Exchange of Hong Kong<br />

11/F United Centre 95 Queensway<br />

Hong Kong<br />

Tel (852) 22776600<br />

Fax (852) 28685307<br />

Websites: www.phillip.com.hk<br />

INDONESIA<br />

PT <strong>Phillip</strong> <strong>Securities</strong> Indonesia<br />

ANZ Tower Level 23B,<br />

Jl Jend Sudirman Kav 33A<br />

Jakarta 10220 – Indonesia<br />

Tel (62-21) 57900800<br />

Fax (62-21) 57900809<br />

Website: www.phillip.co.id<br />

THAILAND<br />

<strong>Phillip</strong> <strong>Securities</strong> (Thailand) Public Co. <strong>Ltd</strong><br />

15th Floor, Vorawat Building,<br />

849 Silom Road, Silom, Bangrak,<br />

Bangkok 10500 Thailand<br />

Tel (66-2) 6351700 / 22680999<br />

Fax (66-2) 22680921<br />

Website www.phillip.co.th<br />

UNITED KINGDOM<br />

King & Shaxson Capital Limited<br />

6th Floor, Candlewick House,<br />

120 Cannon Street,<br />

London, EC4N 6AS<br />

Tel (44-20) 7426 5950<br />

Fax (44-20) 7626 1757<br />

Website: www.kingandshaxson.com<br />

AUSTRALIA<br />

<strong>Phillip</strong>Capital Australia<br />

Level 37, 530 Collins Street,<br />

Melbourne, Victoria 3000, Australia<br />

Tel (613) 96298380<br />

Fax (613) 96148309<br />

Website: www.phillipcapital.com.au<br />

10 of 10<br />

MALAYSIA<br />

<strong>Phillip</strong> Capital Management Sdn Bhd<br />

B-3-6 Block B Level 3 Megan Avenue II,<br />

No. 12, Jalan Yap Kwan Seng, 50450<br />

Kuala Lumpur<br />

Tel (603) 21628841<br />

Fax (603) 21665099<br />

Website: www.poems.com.my<br />

JAPAN<br />

<strong>Phillip</strong> <strong>Securities</strong> Japan, <strong>Ltd</strong>.<br />

4-2 Nihonbashi Kabuto-cho<br />

Chuo-ku, Tokyo 103-0026<br />

Tel (81-3) 36662101<br />

Fax (81-3) 36666090<br />

Website:www.phillip.co.jp<br />

CHINA<br />

<strong>Phillip</strong> Financial Advisory (Shanghai) Co. <strong>Ltd</strong><br />

No 550 Yan An East Road,<br />

Ocean Tower Unit 2318,<br />

Postal code 200001<br />

Tel (86-21) 51699200<br />

Fax (86-21) 63512940<br />

Website: www.phillip.com.cn<br />

FRANCE<br />

King & Shaxson Capital Limited<br />

3rd Floor, 35 Rue de la Bienfaisance 75008<br />

Paris France<br />

Tel (33-1) 45633100<br />

Fax (33-1) 45636017<br />

Website: www.kingandshaxson.com<br />

UNITED STATES<br />

<strong>Phillip</strong> Futures Inc<br />

141 W Jackson Blvd Ste 3050<br />

The Chicago Board of Trade Building<br />

Chicago, IL 60604 USA<br />

Tel +1.312.356.9000<br />

Fax +1.312.356.9005

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!